Cost-effectiveness of immune checkpoint inhibitors as a first-line therapy for advanced hepatocellular carcinoma: a systematic review
Article in Health Economics Review (July 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in Health Economics Review (July 2024)
Article in Cancers (May 2024)
Article in Medicine (April 2024)